182 related articles for article (PubMed ID: 1380789)
1. Identification of the human immunodeficiency virus reverse transcriptase residues that contribute to the activity of diverse nonnucleoside inhibitors.
Condra JH; Emini EA; Gotlib L; Graham DJ; Schlabach AJ; Wolfgang JA; Colonno RJ; Sardana VV
Antimicrob Agents Chemother; 1992 Jul; 36(7):1441-6. PubMed ID: 1380789
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitors.
Sardana VV; Emini EA; Gotlib L; Graham DJ; Lineberger DW; Long WJ; Schlabach AJ; Wolfgang JA; Condra JH
J Biol Chem; 1992 Sep; 267(25):17526-30. PubMed ID: 1381350
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of inhibition of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase by the novel HIV-1-specific nucleoside analogue [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5 "- (4"-amino-1",2"-oxathiole-2",2"-dioxide)thymine (TSAO-T).
Balzarini J; Pérez-Pérez MJ; San-Félix A; Camarasa MJ; Bathurst IC; Barr PJ; De Clercq E
J Biol Chem; 1992 Jun; 267(17):11831-8. PubMed ID: 1376314
[TBL] [Abstract][Full Text] [Related]
4. The genetic and functional basis of HIV-1 resistance to nonnucleoside reverse transcriptase inhibitors.
Emini EA; Byrnes VW; Condra JH; Schleif WA; Sardana VV
Arch Virol Suppl; 1994; 9():11-7. PubMed ID: 7518271
[TBL] [Abstract][Full Text] [Related]
5. Chimeric human immunodeficiency virus type 1/type 2 reverse transcriptases display reversed sensitivity to nonnucleoside analog inhibitors.
Shih CK; Rose JM; Hansen GL; Wu JC; Bacolla A; Griffin JA
Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9878-82. PubMed ID: 1719542
[TBL] [Abstract][Full Text] [Related]
6. A mutation in reverse transcriptase of bis(heteroaryl)piperazine-resistant human immunodeficiency virus type 1 that confers increased sensitivity to other nonnucleoside inhibitors.
Dueweke TJ; Pushkarskaya T; Poppe SM; Swaney SM; Zhao JQ; Chen IS; Stevenson M; Tarpley WG
Proc Natl Acad Sci U S A; 1993 May; 90(10):4713-7. PubMed ID: 7685109
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of residue 190 of human immunodeficiency virus type 1 reverse transcriptase.
Kleim JP; Bender R; Kirsch R; Meichsner C; Paessens A; Riess G
Virology; 1994 May; 200(2):696-701. PubMed ID: 7513921
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous mutations at Tyr-181 and Tyr-188 in HIV-1 reverse transcriptase prevents inhibition of RNA-dependent DNA polymerase activity by the bisheteroarylpiperazine (BHAP) U-90152s.
Fan N; Rank KB; Evans DB; Thomas RC; Tarpley WG; Sharma SK
FEBS Lett; 1995 Aug; 370(1-2):59-62. PubMed ID: 7544302
[TBL] [Abstract][Full Text] [Related]
9. A nonnucleoside reverse transcriptase inhibitor active on human immunodeficiency virus type 1 isolates resistant to related inhibitors.
Goldman ME; O'Brien JA; Ruffing TL; Schleif WA; Sardana VV; Byrnes VW; Condra JH; Hoffman JM; Emini EA
Antimicrob Agents Chemother; 1993 May; 37(5):947-9. PubMed ID: 7685996
[TBL] [Abstract][Full Text] [Related]
10. Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors.
Nunberg JH; Schleif WA; Boots EJ; O'Brien JA; Quintero JC; Hoffman JM; Emini EA; Goldman ME
J Virol; 1991 Sep; 65(9):4887-92. PubMed ID: 1714522
[TBL] [Abstract][Full Text] [Related]
11. 3'-Azido-3'-deoxythymidine resistance suppressed by a mutation conferring human immunodeficiency virus type 1 resistance to nonnucleoside reverse transcriptase inhibitors.
Larder BA
Antimicrob Agents Chemother; 1992 Dec; 36(12):2664-9. PubMed ID: 1282792
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture.
Richman D; Shih CK; Lowy I; Rose J; Prodanovich P; Goff S; Griffin J
Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11241-5. PubMed ID: 1722324
[TBL] [Abstract][Full Text] [Related]
13. Enzymatic properties and sensitivity to inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase with Glu-138-->Arg and Tyr-188-->His mutations.
Zhang H; Vrang L; Bäckbro K; Unge T; Noréen R; Oberg B
Antiviral Res; 1994 May; 24(1):43-57. PubMed ID: 7524439
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of inhibition of endogenous human immunodeficiency virus type 1 reverse transcription by 2',3'-dideoxynucleoside 5'-triphosphate, tetrahydroimidazo-[4,5,1-jk][1,4]-benzodiazepin-2(1H)-thion e, and 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives.
Debyser Z; Vandamme AM; Pauwels R; Baba M; Desmyter J; De Clercq E
J Biol Chem; 1992 Jun; 267(17):11769-76. PubMed ID: 1376311
[TBL] [Abstract][Full Text] [Related]
15. A single conservative amino acid substitution in the reverse transcriptase of human immunodeficiency virus-1 confers resistance to (+)-(5S)-4,5,6,7-tetrahydro-5-methyl-6-(3-methyl-2-butenyl)imidazo[4,5, 1- jk][1,4]benzodiazepin-2(1H)-thione (TIBO R82150).
Mellors JW; Im GJ; Tramontano E; Winkler SR; Medina DJ; Dutschman GE; Bazmi HZ; Piras G; Gonzalez CJ; Cheng YC
Mol Pharmacol; 1993 Jan; 43(1):11-6. PubMed ID: 7678690
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors.
Spence RA; Kati WM; Anderson KS; Johnson KA
Science; 1995 Feb; 267(5200):988-93. PubMed ID: 7532321
[TBL] [Abstract][Full Text] [Related]
17. Construction of the chimeric reverse transcriptase of simian immunodeficiency virus sensitive to nonnucleoside reverse transcriptase inhibitor.
Isaka Y; Sato A; Kawauchi S; Suyama A; Miki S; Hayami M; Fujiwara T
Microbiol Immunol; 1998; 42(3):195-202. PubMed ID: 9570285
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of 2-pyridinone derivatives as HIV-1-specific reverse transcriptase inhibitors. 2. Analogues of 3-aminopyridin-2(1H)-one.
Saari WS; Wai JS; Fisher TE; Thomas CM; Hoffman JM; Rooney CS; Smith AM; Jones JH; Bamberger DL; Goldman ME
J Med Chem; 1992 Oct; 35(21):3792-802. PubMed ID: 1279173
[TBL] [Abstract][Full Text] [Related]
19. Amino acid substitutions in HIV-1 reverse transcriptase with corresponding residues from HIV-2. Effect on kinetic constants and inhibition by non-nucleoside analogs.
Bacolla A; Shih CK; Rose JM; Piras G; Warren TC; Grygon CA; Ingraham RH; Cousins RC; Greenwood DJ; Richman D
J Biol Chem; 1993 Aug; 268(22):16571-7. PubMed ID: 7688367
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of HIV-1 reverse transcriptase by pyridinone derivatives. Potency, binding characteristics, and effect of template sequence.
Carroll SS; Olsen DB; Bennett CD; Gotlib L; Graham DJ; Condra JH; Stern AM; Shafer JA; Kuo LC
J Biol Chem; 1993 Jan; 268(1):276-81. PubMed ID: 7677997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]